Abstract African American/Black individuals have a disproportionate cancer burden,
including the highest mortality and the lowest survival of any racial/ethnic group for most …

Abstract Each year, the American Cancer Society estimates the numbers of new cancer
cases and deaths in the United States and compiles the most recent data on population …

Aims To evaluate current status of prostate cancer incidence and mortality worldwide, and
compare the global trends of incidence and mortality in the past two decades and in the …

Each year, the American Cancer Society estimates the numbers of new cancer cases and
deaths in the United States and compiles the most recent data on population-based cancer …

Background High rates of overdiagnosis are a critical barrier to organized prostate cancer
screening. Magnetic resonance imaging (MRI) with targeted biopsy has shown the potential …

Prostate cancer is the second most frequently diagnosed cancer among men worldwide,
with the estimated sixth leading cause of cancer death. Despite major advancements in …

Abstract Background In the United States, Black men are at highest risk for being diagnosed
with and dying from prostate cancer. Given this disparity, we examined relevant data to …

Accurate and reliable quantification of tumor biomarkers in clinical samples is of vital
importance for early stage diagnosis and treatment of cancer. However, a poor specificity of …

Background Prostate cancer (PC) screening guidelines have changed over the last decade
to reduce overdiagnosis and overtreatment of low-grade disease. We sought to examine …

In the past 20 years, new insights into the genomic pathogenesis of prostate cancer have
been provided. Large-scale integrative genomics approaches enabled researchers to …